Intas launches RAZUMAB, the first biosimilar to Lucentis (ranibizumab)
Ranibizumab is indicated for the treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD), a common degenerative…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.